Cargando…

Misleading Presentation of Euglycemic Diabetic Ketoacidosis: Implication for Low-Mid-Income Communities

Detalles Bibliográficos
Autores principales:	Nwose, Ezekiel Uba, Bwititi, Phillip Taderera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683811/ https://www.ncbi.nlm.nih.gov/pubmed/26713304 http://dx.doi.org/10.4103/1947-2714.170629

Ejemplares similares

Screening of Cardiovascular Disease Risk in Diabetes: Questions Concerning Prediabetes and Low-Mid Income Countries
por: Bwititi, Phillip Taderera, et al.
Publicado: (2014)

Autophagy in Diabetes Pathophysiology: Oxidative Damage Screening as Potential for Therapeutic Management by Clinical Laboratory Methods
por: Nwose, Ezekiel Uba, et al.
Publicado: (2021)

Cost-effectiveness of community diabetes screening: Application of Akaike information criterion in rural communities of Nigeria
por: Anyasodor, Anayochukwu Edward, et al.
Publicado: (2022)

Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis
por: Thawabi, Mohammad, et al.
Publicado: (2015)

Cardiovascular Disease Risk Prevention: Preliminary Survey of Baseline Knowledge, Attitude and Practices of a Nigerian Rural Community
por: Oguoma, Victor Maduabuchi, et al.
Publicado: (2014)

New Guidelines for Diagnosis of Gestational Diabetes: Pathology-Based Impact Assessment
por: Nwose, Ezekiel Uba, et al.
Publicado: (2013)

Does a hospital diabetes inpatient service reduce blood glucose and HbA1c levels? A prospective cohort study
por: Gardiner, Fergus William, et al.
Publicado: (2017)

Services aimed at achieving desirable clinical outcomes in patients with chronic kidney disease and diabetes mellitus: A narrative review
por: Gardiner, Fergus William, et al.
Publicado: (2017)

Cardiovascular Risk Assessment in Prediabetes and Undiagnosed Diabetes Mellitus Study: International Collaboration Research Overview
por: Nwose, Ezekiel Uba, et al.
Publicado: (2013)

Prevalence of Anemia and Risk of Adverse Bleeding Effect of Drugs: Implication for Therapy
por: Uba Nwose, Ezekiel
Publicado: (2012)

Diabetic Ketoacidosis in an Euglycemic Patient
por: Mumtaz, Hassan, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis in Pregnancy
por: de Alencar, Júlio César Garcia, et al.
Publicado: (2019)

Cardiovascular Risks in Prediabetes: Preliminary Data on “Vasculopathy Triad”
por: Nwose, Ezekiel U, et al.
Publicado: (2014)

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Albugami, Muneerah M., et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis and COVID‐19: A combination to foresee in pregnancy
por: Velasco, Inés, et al.
Publicado: (2021)

A Case of Colchicine Toxicity Presenting With Euglycemic Diabetic Ketoacidosis
por: Delshad, Sean D, et al.
Publicado: (2023)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Euglycemic diabetic ketoacidosis associated with uremia
por: Zhang, Mingxia, et al.
Publicado: (2020)

Whole blood viscosity issues VII: The correlation with leucocytosis and implication on leukapheresis
por: Nwose, Ezekiel Uba, et al.
Publicado: (2010)

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
por: Yu, Xiaofang, et al.
Publicado: (2018)

Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis
por: Chaudhry, Arslan, et al.
Publicado: (2021)

An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists
por: Kang, Cyra-Yoonsun, et al.
Publicado: (2022)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis: A missed diagnosis
por: Nasa, Prashant, et al.
Publicado: (2021)

Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis
por: Badwal, Karun, et al.
Publicado: (2018)

Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation
por: Nwose, Ezekiel Uba
Publicado: (2010)

Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia
por: Nwose, Ezekiel Uba
Publicado: (2010)

Laboratory evaluations to optimize outcomes of antioxidant nutrition therapy in diabetes management
por: Nwose, Ezekiel Uba
Publicado: (2009)

CARDIOVASCULAR RISK ASSESSMENT AND SUPPORT TECHNIQUES: Whole blood viscosity assessment issues I: Extrapolation chart and reference values
por: Nwose, Ezekiel Uba
Publicado: (2010)

Whole blood viscosity assessment issues II: Prevalence in endothelial dysfunction and hypercoagulation
por: Nwose, Ezekiel Uba
Publicado: (2010)

Quality in Diagnostic Microbiology: Experiential Note to Emphasize Value of Internal Control Programs
por: Nwose, Ezekiel Uba
Publicado: (2013)

Blood Viscosity, Lipid Profile and Lipid Peroxidation in Type-1 Diabetic Patients with Good and Poor Glycemic Control: The Promise and Reality
por: Nwose, Ezekiel Uba
Publicado: (2013)

Metabolic Signatures of Oxidative Stress in the Red Blood Cells: Editorial Commentary
por: Nwose, Ezekiel Uba
Publicado: (2015)

Immediate Euglycemic Diabetic Ketoacidosis After Gastric Bypass in a Patient with Type II Diabetes
por: Lo, Yu-Ting, et al.
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication
por: Abu-Abed Abdin, Asma, et al.
Publicado: (2016)

Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin
por: Adachi, Junichiro, et al.
Publicado: (2017)

Combined metformin-associated lactic acidosis and euglycemic ketoacidosis
por: Schwetz, Verena, et al.
Publicado: (2017)

Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma
por: Rawla, Prashanth, et al.
Publicado: (2017)

Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019)

Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8dgn5q1a2q0a6a4otp642adnb